AIM ImmunoTech is trading at $0.17, up 5.47% in pre-market, with no clear company-specific catalyst identified for the October 23 gain.
- The latest company press release found in the search was dated October 7.
- Supplied market indicators are mixed and do not establish a broad-market explanation; pre-market volume or trading activity data was not provided.
- Available evidence does not confirm why the stock is moving.